InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.00%
)
US TECH 100
18,362.40
(
0.24%
)
Dow Jones
39,069.59
(
0.00%
)
Brent Oil
83.20
(
0.43%
)
Bitcoin
68,156.84
(
-1.78%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ilpapa

Send PM Follow Ignore
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

ilpapa

Re: Jesspro post# 61811

Thursday, 04/16/2015 7:34:26 AM

Thursday, April 16, 2015 7:34:26 AM

Post# of 80490
Seems to be a disconnect here.

Ariad Pharmaceuticals (NASDAQ:ARIA) was downgraded by equities research analysts at Vetr from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. They currently have a $10.56 price target on the stock. Vetr‘s price objective suggests a potential upside of 18.38% from the stock’s previous close.

Separately, analysts at HC Wainright set a $10.00 price target on shares of Ariad Pharmaceuticals and gave the company a “buy” rating in a research note on Monday, February 23rd.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up